| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.10. | Goldman Sachs upgrades Sysmex stock to Buy on growth re-evaluation | 18 | Investing.com | ||
| 10.10. | Goldman Sachs stuft Sysmex-Aktie hoch: Neubewertung des Wachstumspotenzials erwartet | 26 | Investing.com Deutsch | ||
| 01.10. | Sysmex, QIAGEN Announce Exclusive Distribution Partnership For Diagnostic Products In Japan | 715 | AFX News | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) and QIAGEN K.K., the Japanese subsidiary of QIAGEN N.V., announced on Wednesday that they have entered into a partnership for clinical diagnostic... ► Artikel lesen | |
| 06.08. | Sysmex reports FQ1 results | 87 | Seeking Alpha | ||
| 06.08. | Sysmex Q1 Profit Declines | 1.082 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex reported first quarter profit attributable to owners of the parent of 4.55 billion yen, down 58.7% from last year. Earnings per share was 7.30 yen... ► Artikel lesen | |
| 15.04. | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | 832 | PR Newswire | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
| 01.04. | Sysmex Europe SE: Sysmex's PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision | 781 | GlobeNewswire (Europe) | Sysmex's PA-100 AST System reduces the time for UTI diagnosis to 15 minutes and determines the optimal antibiotic within 30 minutes. A recently published budget impact analysis suggests potential healthcare... ► Artikel lesen | |
| SYSMEX CORPORATION ADR Aktie jetzt für 0€ handeln | |||||
| 01.04. | EQS-Media: Sysmex Europe SE: Das PA-100 AST-System von Sysmex: Revolutionierung der Diagnose und Behandlung von Harnwegsinfektionen mit Präzision | 1.058 | EQS Group (DE) | EQS-Media / 01.04.2025 / 10:08 CET/CEST
Das System verkürzt die Zeit für die Diagnose von Harnwegsinfektionen auf nur 15 Minuten und bestimmt die optimalen Antibiotika innerhalb von 30... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RESMED | 216,40 | +0,93 % | Resmed Inc Q3 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) announced a profit for its third quarter that Increased from last year and beat the Street estimates.The company's earnings totaled $348.5 million... ► Artikel lesen | |
| CARDINAL HEALTH | 166,00 | +0,27 % | Cardinal Health, Inc.: Cardinal Health Reports First Quarter Fiscal Year 2026 Results and Raises Outlook |
Revenue increased 22% to $64 billion
GAAP 1 operating earnings increased 18% to $668 million; GAAP diluted EPS increased 11% to $1.88
Non-GAAP operating... ► Artikel lesen | |
| UNIDOC HEALTH | 0,112 | -4,75 % | UniDoc Health Corp.: UniDoc Closes Fully Subscribed LIFE Offering | THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / October 27, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)... ► Artikel lesen | |
| ZIMMER BIOMET | 87,88 | +0,55 % | Zimmer Biomet Receives FDA Breakthrough Device Status For Iodine-Treated Hip Replacement System | WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, said Tuesday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,418 | +4,50 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| CLARIANE | 3,644 | -2,20 % | Clariane: Revenue for the nine months ended 30 September 2025 | Press release Third-quarter organic revenue growth of +5.1% Year to date revenue at 30 September 2025 reached €3,976m, an increase of +4.9% on an organic basisAll activities and regions contributed... ► Artikel lesen | |
| PANGENOMIC HEALTH | 0,775 | +6,16 % | Gesundheit als Milliardenmarkt: PanGenomic Health, Hims & Hers, WW International | Immer mehr Menschen kümmern sich proaktiv um ihre Gesundheit - Vorsorge und Selbstfürsorge liegen im Trend. Laut aktuellen Studien von McKinsey ist die globale Wellness-Branche inzwischen rund 2 Billionen... ► Artikel lesen | |
| IZOTROPIC | 0,270 | -4,26 % | Izotropic Corporation: Izotropic Launches "Breast Imaging News" Page on BreastCT.com | Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical... ► Artikel lesen | |
| INSPIREMD | 1,850 | -2,63 % | InspireMD Inc.: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIAMI, Oct. 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| VYOME | 6,050 | +8,04 % | Morning Market Movers: SciSparc, Vyome Holdings, Presidio Property Trust, FG Nexus See Big Swings | BEIJING (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ASTRANA HEALTH | 28,200 | +3,68 % | Ehepartner von US-Abgeordneter Judy Chu tätigt signifikante Transaktionen mit Aktien von Astrana Health Inc. | ||
| ORGANOGENESIS | 3,640 | -0,55 % | Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| CATHETER PRECISION | 2,510 | +4,58 % | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| CROSSJECT | 2,415 | +0,42 % | CROSSJECT presents its financial results and key highlights for the first half of 2025 | Press release CROSSJECT presents its financial results and key highlights for the first half of 2025 Cash position: €6.3 million, compared to €7.0 million as of December 31 2024, demonstrating the... ► Artikel lesen | |
| ORIOLA | 1,164 | -0,85 % | Oriola Corporation: Oriola Corporation's Interim Report January-September 2025 | Oriola Corporation Stock Exchange Release 30 October 2025 at 8.30 a.m. EET
Oriola Corporation's Interim Report January-September 2025
Sales margin growth and improved adjusted EBITDA
July-September... ► Artikel lesen |